Female Femroids Liquid
NDC Package 55714-4769-1
Package Information
Female Femroids (hydrastis canadensis, thuja occidentalis, arsenicum album, calcarea iodata, carbo animalis, conium maculatum, graphites, hydrastis canadensis, iodium, kreosotum, lachesis mutus, phosphorus, sabina, secale cornutum, sepia, silicea, thlaspi bursa-pastoris, thuja occidentalis, thyroidinum, trillium pendulum, ustilago maidis.) liquids is formulated for symptoms such as heavy or prolonged menses and/or pelvic discomfort. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4769.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 15 [hp_X]/mL
- CALCIUM IODIDE 15 [hp_X]/mL
- CAPSELLA BURSA-PASTORIS 15 [hp_X]/mL
- CARBO ANIMALIS 15 [hp_X]/mL
- CLAVICEPS PURPUREA SCLEROTIUM 15 [hp_X]/mL
- CONIUM MACULATUM FLOWERING TOP 15 [hp_X]/mL
- GOLDENSEAL 15 [hp_X]/mL
- GRAPHITE 15 [hp_X]/mL
- IODINE 15 [hp_X]/mL
- JUNIPERUS SABINA LEAFY TWIG 15 [hp_X]/mL
- LACHESIS MUTA VENOM 15 [hp_X]/mL
- PHOSPHORUS 15 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 15 [hp_X]/mL
- SILICON DIOXIDE 15 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 15 [hp_X]/mL
- THYROID, UNSPECIFIED 15 [hp_X]/mL
- TRILLIUM ERECTUM ROOT 15 [hp_X]/mL
- USTILAGO MAYDIS 15 [hp_X]/mL
- WOOD CREOSOTE 15 [hp_X]/mL
- Allergens - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Fungal Proteins - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Fungal Allergenic Extract - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4769 - Female Femroids
- 55714-4769-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4769 - Female Femroids
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4769-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Female Femroids, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains arsenic trioxide; calcium iodide; capsella bursa-pastoris; carbo animalis; claviceps purpurea sclerotium; conium maculatum flowering top; goldenseal; graphite; iodine; juniperus sabina leafy twig; lachesis muta venom; phosphorus; sepia officinalis juice; silicon dioxide; thuja occidentalis leafy twig; thyroid, unspecified; trillium erectum root; ustilago maydis; wood creosote as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 02, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714476901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.